Articles about 'Tuomas Knowles'

10 companies taking Cambridge ideas out of the lab and into the real world to address the climate emergency.

For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments.

Researchers have created a plant-based, sustainable, scalable material that could replace single-use plastics in many consumer products.

Five researchers at the University of Cambridge have won consolidator grants from the European Research Council (ERC), Europe’s premiere funding organisation for frontier research.

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases.

Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease. 

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge. 

Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and progression of Alzheimer’s disease. 

A new design of algae-powered fuel cells that is five times more efficient than existing plant and algal models, as well as being potentially more cost-effective to produce and practical to use, has been developed by researchers at the University of Cambridge. 

Gifts totalling more than £32 million, together with government funds of over £17 million, have enabled the launch of a highly innovative Centre in Cambridge that is pioneering new approaches to understand and treat neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, motor neurone disease and frontotemporal dementia.